High chylomicron remnant causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Rim Halaby (talk | contribs) |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
High chylomicron remnants level can either be due to [[genetic]] conditions as in [[Hyperlipoproteinemia|type I and type V hyperlipoproteinemia]] or can be secondary to conditions such as [[chronic renal failure]], [[hypothyroidism]], and [[diabetes mellitus]]. | |||
==Causes== | ==Causes== | ||
| Line 58: | Line 58: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[Familial hypertriglyceridemia]], [[fructose-1-phosphate aldolase deficiency]], [[galactosemia]], [[glycogen storage disease type I]], [[glycogen storage disease type IV]], [[lipoprotein lipase deficiency]], [[mixed hyperlipoproteinemia]], [[familial hyperchylomicronemia|type 1C hyperlipoproteinemia]], [[ | |bgcolor="Beige"| [[Familial hypertriglyceridemia]], [[fructose-1-phosphate aldolase deficiency]], [[galactosemia]], [[glycogen storage disease type I]], [[glycogen storage disease type IV]], [[lipoprotein lipase deficiency]], [[mixed hyperlipoproteinemia]], [[familial hyperchylomicronemia|type 1C hyperlipoproteinemia]], [[tyrosinemia type 1]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 82: | Line 82: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| [[Familial hypertriglyceridemia]], [[glycogen storage disease type I]], [[glycogen storage disease type IV]], [[carbohydrate|high carbohydrate diet]], [[fat|high saturated fat diet]], [[HDL|isolated low HDL]], [[lipoprotein lipase deficiency]] | |bgcolor="Beige"| [[Familial hypertriglyceridemia]], [[glycogen storage disease type I]], [[glycogen storage disease type IV]], [[carbohydrate|high carbohydrate diet]], [[fat|high saturated fat diet]], [[Low HDL|isolated low HDL]], [[lipoprotein lipase deficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 149: | Line 149: | ||
*[[Dialysis]]<ref name="pmid1453610">{{cite journal| author=Weintraub M, Burstein A, Rassin T, Liron M, Ringel Y, Cabili S et al.| title=Severe defect in clearing postprandial chylomicron remnants in dialysis patients. | journal=Kidney Int | year= 1992 | volume= 42 | issue= 5 | pages= 1247-52 | pmid=1453610 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1453610 }} </ref> | *[[Dialysis]]<ref name="pmid1453610">{{cite journal| author=Weintraub M, Burstein A, Rassin T, Liron M, Ringel Y, Cabili S et al.| title=Severe defect in clearing postprandial chylomicron remnants in dialysis patients. | journal=Kidney Int | year= 1992 | volume= 42 | issue= 5 | pages= 1247-52 | pmid=1453610 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1453610 }} </ref> | ||
*[[Familial hyperchylomicronemia|Type 1B hyperlipoproteinemia]] | *[[Familial hyperchylomicronemia|Type 1B hyperlipoproteinemia]] | ||
{{col-break|width=33%}} | |||
*[[Familial hypertriglyceridemia]] | *[[Familial hypertriglyceridemia]] | ||
*[[Fructose-1-phosphate aldolase deficiency]] | *[[Fructose-1-phosphate aldolase deficiency]] | ||
*[[Galactosemia]] | *[[Galactosemia]] | ||
| Line 161: | Line 161: | ||
*[[fat|High saturated fat diet]] | *[[fat|High saturated fat diet]] | ||
*[[Hypothyroidism]]<ref name="pmid12699445">{{cite journal| author=Ito M, Takamatsu J, Matsuo T, Kameoka K, Kubota S, Fukata S et al.| title=Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement. | journal=Clin Endocrinol (Oxf) | year= 2003 | volume= 58 | issue= 5 | pages= 621-6 | pmid=12699445 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12699445 }} </ref> | *[[Hypothyroidism]]<ref name="pmid12699445">{{cite journal| author=Ito M, Takamatsu J, Matsuo T, Kameoka K, Kubota S, Fukata S et al.| title=Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement. | journal=Clin Endocrinol (Oxf) | year= 2003 | volume= 58 | issue= 5 | pages= 621-6 | pmid=12699445 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12699445 }} </ref> | ||
*[[HDL|Isolated low HDL]]<ref name="pmid16458316">{{cite journal| author=Benjó AM, Maranhão RC, Coimbra SR, Andrade AC, Favarato D, Molina MS et al.| title=Accumulation of chylomicron remnants and impaired vascular reactivity occur in subjects with isolated low HDL cholesterol: effects of niacin treatment. | journal=Atherosclerosis | year= 2006 | volume= 187 | issue= 1 | pages= 116-22 | pmid=16458316 | doi=10.1016/j.atherosclerosis.2005.08.025 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16458316 }} </ref> | *[[Low HDL|Isolated low HDL]]<ref name="pmid16458316">{{cite journal| author=Benjó AM, Maranhão RC, Coimbra SR, Andrade AC, Favarato D, Molina MS et al.| title=Accumulation of chylomicron remnants and impaired vascular reactivity occur in subjects with isolated low HDL cholesterol: effects of niacin treatment. | journal=Atherosclerosis | year= 2006 | volume= 187 | issue= 1 | pages= 116-22 | pmid=16458316 | doi=10.1016/j.atherosclerosis.2005.08.025 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16458316 }} </ref> | ||
{{col-break|width=33%}} | |||
*[[Familial hyperchylomicronemia|Lipoprotein lipase deficiency]]<ref name="pmid8468529">{{cite journal| author=Brasaemle DL, Cornely-Moss K, Bensadoun A| title=Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E. | journal=J Lipid Res | year= 1993 | volume= 34 | issue= 3 | pages= 455-65 | pmid=8468529 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8468529 }} </ref> | *[[Familial hyperchylomicronemia|Lipoprotein lipase deficiency]]<ref name="pmid8468529">{{cite journal| author=Brasaemle DL, Cornely-Moss K, Bensadoun A| title=Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E. | journal=J Lipid Res | year= 1993 | volume= 34 | issue= 3 | pages= 455-65 | pmid=8468529 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8468529 }} </ref> | ||
*[[Glucocorticoids]] | *[[Glucocorticoids]] | ||
*[[Isotretinoin]] | *[[Isotretinoin]] | ||
| Line 174: | Line 173: | ||
*[[Thiazide|Thiazide diuretics]] | *[[Thiazide|Thiazide diuretics]] | ||
*[[Familial hyperchylomicronemia|Type 1C hyperlipoproteinemia]] | *[[Familial hyperchylomicronemia|Type 1C hyperlipoproteinemia]] | ||
*[[ | *[[Tyrosinemia type 1]] | ||
*[[Wilson's disease]] | *[[Wilson's disease]] | ||
{{col-end}} | {{col-end}} | ||
Latest revision as of 17:50, 20 November 2013
|
Chylomicron Remnant Microchapters |
|
Clinical Correlation |
|---|
|
Treatment |
|
Case Studies |
|
High chylomicron remnant causes On the Web |
|
American Roentgen Ray Society Images of High chylomicron remnant causes |
|
Risk calculators and risk factors for High chylomicron remnant causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Overview
High chylomicron remnants level can either be due to genetic conditions as in type I and type V hyperlipoproteinemia or can be secondary to conditions such as chronic renal failure, hypothyroidism, and diabetes mellitus.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Alcoholism
- Chronic renal failure
- Diabetes mellitus
- Hypothyroidism
- Oral contraceptives
- Pregnancy
- Thiazide diuretics
Causes by Organ System
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | No underlying causes |
| Dental | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | Antiretroviral therapy, atypical antipsychotics, glucocorticoids, heparin, isotretinoin, oral contraceptives, tamoxifen, thiazide diuretics |
| Ear Nose Throat | No underlying causes |
| Endocrine | Diabetes mellitus, hypothyroidism |
| Environmental | No underlying causes |
| Gastroenterologic | Acute pancreatitis, alcoholic liver disease, cirrhosis, hepatitis, hereditary hemochromatosis, non-alcoholic steatohepatitis (NASH), Wilson's disease |
| Genetic | Familial hypertriglyceridemia, fructose-1-phosphate aldolase deficiency, galactosemia, glycogen storage disease type I, glycogen storage disease type IV, lipoprotein lipase deficiency, mixed hyperlipoproteinemia, type 1C hyperlipoproteinemia, tyrosinemia type 1 |
| Hematologic | No underlying causes |
| Iatrogenic | Dialysis |
| Infectious Disease | No underlying causes |
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional/Metabolic | Familial hypertriglyceridemia, glycogen storage disease type I, glycogen storage disease type IV, high carbohydrate diet, high saturated fat diet, isolated low HDL, lipoprotein lipase deficiency |
| Obstetric/Gynecologic | Pregnancy |
| Oncologic | No underlying causes |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | No underlying causes |
| Renal/Electrolyte | Acute renal failure, chronic renal failure, nephrotic syndrome |
| Rheumatology/Immunology/Allergy | Autoimmune hyperchylomicronemia [1] |
| Sexual | No underlying causes |
| Trauma | No underlying causes |
| Urologic | No underlying causes |
| Miscellaneous | Alcoholism |
Causes by Alphabetical Order
References
- ↑ 1.0 1.1 Yoshimura, T.; Ito, M.; Sakoda, Y.; Kobori, S.; Okamura, H. (1998). "Rare case of autoimmune hyperchylomicronemia during pregnancy". Eur J Obstet Gynecol Reprod Biol. 76 (1): 49–51. PMID 9481547. Unknown parameter
|month=ignored (help) - ↑ Weintraub M, Burstein A, Rassin T, Liron M, Ringel Y, Cabili S; et al. (1992). "Severe defect in clearing postprandial chylomicron remnants in dialysis patients". Kidney Int. 42 (5): 1247–52. PMID 1453610.
- ↑ Ito M, Takamatsu J, Matsuo T, Kameoka K, Kubota S, Fukata S; et al. (2003). "Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement". Clin Endocrinol (Oxf). 58 (5): 621–6. PMID 12699445.
- ↑ Benjó AM, Maranhão RC, Coimbra SR, Andrade AC, Favarato D, Molina MS; et al. (2006). "Accumulation of chylomicron remnants and impaired vascular reactivity occur in subjects with isolated low HDL cholesterol: effects of niacin treatment". Atherosclerosis. 187 (1): 116–22. doi:10.1016/j.atherosclerosis.2005.08.025. PMID 16458316.
- ↑ Brasaemle DL, Cornely-Moss K, Bensadoun A (1993). "Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E." J Lipid Res. 34 (3): 455–65. PMID 8468529.